Vicki Finlayson could barely walk from one room to another before Low Dose Naltrexone (LDN) gave her the victory over the debilitating effects of MS.

Now, Ms. Finlayson is planning to walk fifty-three miles on may 19th to raise funds and awareness for researching the efficacy of LDN in treating MS.

For more information about LDN, visit ldners.org